Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same author

Nuclear Enlargement as a Histological Hallmark of Skeletal Muscle Aging, Revealed by Deep Learning-Driven Analysis and Validated in Inflammatory Myopathies.

Aging cell·2026
Same author

Hierarchical ceria nanoarchitecture enabling accelerated lattice oxygen activation for efficient redox reactions.

Nature communications·2026
Same author

SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities.

Cancer discovery·2026
Same author

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation.

Nano convergence·2026
Same author

Advancing understanding of long COVID pathophysiology through quantum walk-based network analysis.

Bioinformatics advances·2026
Same journal

Classification of periapical radiographic findings for root canal therapy decision support using deep neural networks.

BMC medical informatics and decision making·2026
Same journal

Machine learning-based risk assessment of neonatal perinatal adverse outcomes of anemia during pregnancy: a modeling study.

BMC medical informatics and decision making·2026
Same journal

Intelligent differentiation between Parkinson's disease and essential tremor using wearable sensors and machine learning: a temporal validation study.

BMC medical informatics and decision making·2026
Same journal

Risk prediction of sepsis-associated acute kidney injury: development, validation of a machine learning model with multicenter data.

BMC medical informatics and decision making·2026
Same journal

Trajectory analysis of sleep disorders and anxiety-depression in female breast cancer patients undergoing chemotherapy: based on group-based Multi-Trajectory Model and machine learning.

BMC medical informatics and decision making·2026
Same journal

Multitask learning of longitudinal circulating biomarkers and clinical outcomes: identification of optimal machine-learning and deep-learning models.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Rule-based multi-scale simulation for drug effect pathway analysis.

Woochang Hwang1, Yongdeuk Hwang, Sunjae Lee

  • 1Department of Bio and Brain Engineering, KAIST, Daejeon, South Korea.

BMC Medical Informatics and Decision Making
|April 10, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a novel rule-based multi-scale modeling platform to predict drug efficacy and interactions for Type 2 diabetes (T2D). Simulations reveal drug mechanisms and guide the development of effective combination therapies, reducing experimental costs.

More Related Videos

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

Related Experiment Videos

Last Updated: May 12, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

Area of Science:

  • Computational biology
  • Pharmacology
  • Systems biology

Background:

  • Biological systems exhibit robustness, but drugs often have limited efficacy and side effects.
  • Combination drug therapies can enhance efficacy and reduce side effects but are costly to test experimentally.
  • Existing computational models struggle with distant interactions beyond localized pathways.

Purpose of the Study:

  • To develop a rule-based multi-scale modeling platform for simulating biological systems.
  • To evaluate the efficacy of single and combination drug therapies for Type 2 diabetes (T2D).
  • To understand drug mechanisms and guide drug development.

Main Methods:

  • Developed a rule-based multi-scale modeling platform.
  • Curated 190 T2D-related rules from literature and databases.
  • Simulated the effects of 22 T2D drugs on a multi-scale T2D model.

Main Results:

  • The platform successfully modeled T2D involving multiple organs.
  • Simulations identified drug effect pathways for T2D drugs.
  • The study assessed the efficacy of combination drugs and their mechanisms of action.

Conclusions:

  • The simulation platform aids in understanding drug mechanisms for drug development.
  • It offers a new approach for repurposing existing drugs.
  • Provides insights for identifying effective combination drug therapies.